-
ESPR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Esperion Therapeutics (ESPR)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 144.72 mm | 144.72 mm | 144.72 mm | 144.72 mm | 144.72 mm | 144.72 mm |
Cash burn (monthly) | 14.86 mm | (no burn) | 5.34 mm | (no burn) | 11.78 mm | 2.15 mm |
Cash used (since last report) | 64.88 mm | n/a | 23.32 mm | n/a | 51.40 mm | 9.37 mm |
Cash remaining | 79.83 mm | n/a | 121.40 mm | n/a | 93.31 mm | 135.35 mm |
Runway (months of cash) | 5.4 | n/a | 22.7 | n/a | 7.9 | 63.1 |
13F holders | Current |
---|---|
Total holders | 188 |
Opened positions | 30 |
Closed positions | 25 |
Increased positions | 49 |
Reduced positions | 44 |
13F shares | Current |
---|---|
Total value | 211.97 bn |
Total shares | 144.57 mm |
Total puts | 929.60 k |
Total calls | 1.67 mm |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
Wasatch Advisors | 23.35 mm | $38.52 bn |
BlackRock | 14.26 mm | $23.54 bn |
Vanguard | 13.04 mm | $21.52 bn |
BLVGF Bellevue | 9.94 mm | $16.41 bn |
BBBOF BB Biotech | 9.19 mm | $18.57 mm |
Kairos Capital Management | 6.58 mm | $10.86 bn |
Flynn James E | 5.00 mm | $0.00 |
Geode Capital Management | 4.33 mm | $7.15 bn |
STT State Street | 3.85 mm | $6.36 bn |
Meditor | 3.79 mm | $6.26 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jan 25 | Eric Warren | Common Stock | Sell | Dispose S | No | No | 2.26 | 123 | 277.98 | 159,998 |
17 Jan 25 | Benjamin Halladay | Common Stock | Sell | Dispose S | No | No | 2.265 | 9 | 20.39 | 240,682 |
17 Dec 24 | Sheldon L. Koenig | Common Stock | Sell | Dispose S | No | No | 2.466 | 12,447 | 30.69 k | 739,819 |
17 Dec 24 | Eric Warren | Common Stock | Sell | Dispose S | No | No | 2.429 | 2,234 | 5.43 k | 160,121 |
17 Dec 24 | Benjamin Halladay | Common Stock | Sell | Dispose S | No | No | 2.424 | 3,245 | 7.87 k | 240,691 |